BDX vs PROF · P/E 34, rev $21.84B vs rev $10.7M
Becton Dickinson and Company (BDX) versus Profound Medical Corp (PROF) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. Revenue was up 8.2% from 2024-09-30 to 2025-09-30. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. PROF currently screens at market cap $238.7M.
Not investment advice. Open the BDX and PROF stock pages for the full models.
Not investment advice.